Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-024862
Filing Date
2025-02-21
Accepted
2025-02-21 16:15:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 24622
2 EXHIBIT 2 - NONBINDING PROPOSAL LETTER ck0001459200-ex2.htm EX-2 22324
  Complete submission text file 0000950170-25-024862.txt   48841
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Subject) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91734 | Film No.: 25652089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 171 MAIN STREET SUITE 259 LOS ALTOS CA 94022
Business Address 171 MAIN STREET SUITE 259 LOS ALTOS CA 94022 650-209-9500
ABeeC 2.0, LLC (Filed by) CIK: 0001869643 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13D/A